More tools:Markets·Screener·Research·Chat

Enovis Corporation (ENOV) Financial Statements

Enovis Corporation
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG001SC04J1
XNYS · usd
19.98▲ 1.42 (7.65%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close18.56
Day's Range18.57 – 20.22
52-Week Range18.52 – 34.28
Volume3.7M
Avg Volume1.4M
Share Statistics
Shares Outstanding
Employees7,802
ExchangeXNYS
Listed2008-05-08
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Enovis Corporation (ENOV)
What is Enovis Corporation's Market Cap?
Enovis Corporation's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's Enterprise Value?
Enovis Corporation's Enterprise Value is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's Price / Sales?
Enovis Corporation's Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's EV / Revenue?
Enovis Corporation's EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's EV / EBITDA?
Enovis Corporation's EV / EBITDA is 7.6×, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's Revenue (TTM)?
Enovis Corporation's Revenue (TTM) is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's Net Income (TTM)?
Enovis Corporation's Net Income (TTM) is -$1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's EBITDA?
Enovis Corporation's EBITDA is $308.8M, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's Diluted EPS (TTM)?
Enovis Corporation's Diluted EPS (TTM) is -19.10, based on as-reported figures from SEC (XBRL) filings.
What is Enovis Corporation's EBITDA Margin?
Enovis Corporation's EBITDA Margin is 13.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 3, 2026Apr 3, 2026Dec 31, 2025Oct 3, 2025Jul 4, 2025Apr 4, 2025Dec 31, 2024Sep 27, 2024Jun 28, 2024Mar 29, 2024Dec 31, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022
Net sales
YoY growth+3.2%+5.4%+2.6%+8.6%+7.5%
Cost of sales
Gross profit
% of revenue61.6%62.0%60.7%59.9%59.3%
Selling, general and administrative expense
Research and development expense
Amortization of acquired intangibles
Purchase of royalty interest
Restructuring charges
Operating income (loss)
% of revenue3.0%1.1%-87.2%-101.7%-3.0%
Interest expense, net
Other (income) expense, net
Income (loss) from continuing operations before income taxes
Income tax expense
Net loss from continuing operations
Net loss
% of revenue-0.2%-1.4%-90.4%-104.0%-6.5%
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes
Net loss attributable to Enovis Corporation
% of revenue-0.2%-1.5%-90.4%-104.1%-6.5%
Net income (loss) per share, consolidated, basic (in usd per share)—
Net income (loss) per share, consolidated, diluted (in usd per share)—